AI assistant
Pluri Inc. — Director's Dealing 2014
Sep 22, 2014
6990_dirs_2014-09-22_9507223f-dc8d-42c5-acfa-10a29fbe3b91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2014-09-21
Reporting Person: Aberman Zami (Director, CEO & Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-21 | Common Stock | P | 2500 | $2.94 | Acquired | 1747798 | Direct |
| 2014-09-21 | Common Stock | P | 2500 | $2.97 | Acquired | 1750298 | Direct |
Footnotes
F1: The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.72, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.643 per U.S. dollar.
F2: The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.83, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.643 per U.S. dollar.